Top Invicta FC flyweight Andrea ‘KGB’ Lee broke the news that she had failed a drug test.
https://twitter.com/AndreaKGBLee/status/715638867303337984
“I just received an email from the Nevada athletic commission saying I am suspended till further notice due to the use of a diuretic, (which makes you pee more),” she wrote. “I have not taken any drugs or any supplements that will help enhance my performance, so do not get your facts wrong! You’re hearing this from me first! Once I know more I will let yall know.”
NAC executive director Bob Bennett confirmed that Lee had failed a urine test, as she tested positive for canrenone and/or spironolactone?, which are both classified as diuretics. As noted, the has been temporarily by the Nevada Athletic Commission, pending a full hearing.
The failed test was in relation toInvicta FC 16 on March 11 in Las Vegas, where she lost via Submission (rear-naked choke) to Sarah D’Alelio. As Lee lost the fight, she does not face an overturning of the fight result.
Invicta FC issued a formal statement.
On Thursday, March 31, Invicta Fighting Championships was notified by the Nevada Athletic Commission (NAC) that flyweight fighter Andrea Lee tested positive for the presence of prohibited diuretics in her pre-fight drug test at Invicta FC 16.
As a result of the positive test, Lee’s license has been temporarily suspended by NAC with a disciplinary hearing forthcoming. Invicta FC will fully cooperate with the NAC on the matter and supports Lee’s right to due process.
Invicta FC consistently informs its athletes about established policies and expectations in regard to conduct, including the strictly prohibited use of performance enhancing drugs, stimulants and masking agents. This positive test represents a violation of those policies.
Current NAC guidelines, note that there is a two-year suspension and a fine of up to 40% of purse for a first time failure of a test for diuretics. The last woman to fail a diuretics test in Nevada was UFC bantamweight Ashlee Evans-Smith, who received a nine month suspension.
